Welch, Holme & Clark Co., Inc

Form 483 issued July 10, 2024 · Newark, New Jersey

Inspection
Jul 1 – Jul 10, 2024
Investigator
Victoria Spivak
Observations
3
Pages
3
FEI number
2211876

In short: On July 10, 2024, FDA issued a Form 483 with 3 observations to Welch, Holme & Clark Co., Inc in Newark, New Jersey (FEI 2211876) after an inspection that ran Jul 1 – Jul 10, 2024. The investigator was Victoria Spivak. Most observations concern quality system and facilities & equipment.

At a glance

2 of 3 observations on this 483 concern quality system.

Quality system2
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Appropriate controls are not exercised over computers or related systems to assure that changes in master…

  2. 02

    The responsibilities and procedures applicable to the quality control unit…

  3. 03

    GMP training is not conducted on a continuing basis and with sufficient frequency to assure that…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Welch, Holme & Clark Co., Inc?

FDA listed 3 observations on this Form 483, mostly about quality system and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Welch, Holme & Clark Co., Inc?

Victoria Spivak is named on this Form 483, for the inspection of Jul 1 – Jul 10, 2024. Each investigator has a profile showing what they cite most.

When was Welch, Holme & Clark Co., Inc inspected by FDA?

The inspection ran Jul 1 – Jul 10, 2024, and the Form 483 is dated July 10, 2024.

How do I get the full Form 483 for Welch, Holme & Clark Co., Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free